We are live on ! Find out more
OCDX

Ortho Clinical Diagnostics Holdings

Delisted

OCDX was delisted on the 26th of May, 2022.

140 hedge funds and large institutions have $4.31B invested in Ortho Clinical Diagnostics Holdings in 2021 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 70 increasing their positions, 22 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,133% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 3

218% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 22

143% more call options, than puts

Call options by funds: $2.35M | Put options by funds: $966K

32% more funds holding

Funds holding: 106 → 140 (+34)

2% more capital inflows, than outflows

Capital inflows: $599M | Capital outflows: $588M

0.54% more ownership

Funds ownership: 98.71% → 99.25% (+0.54%)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
140
Holders Change
+34
Holders Change %
+32.08%
% of All Funds
2.44%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
37
Increased
70
Reduced
22
Closed
3
Calls
$2.35​M
Puts
$966​K
Net Calls
+$1.38​M
Net Calls Change
-⁠$6.45​M

OCDX Hedge Fund Activity: Q3 2021 in Review

140 of the 5,730 institutional investors tracked by Wall St. Rank reported a position in Ortho Clinical Diagnostics Holdings (OCDX) for Q3 2021, worth a combined $4.31B — down 13% from $4.95B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new OCDX positions and 3 closed out — a net gain of 34 holders — while 70 added to existing stakes and 22 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $81.9M. The largest seller was Carlyle Group, cutting an estimated $509M.

  • 140 institutional investors held Ortho Clinical Diagnostics Holdings (OCDX) as of Q3 2021, up from 106 in Q2 2021.
  • Funds reported $4.31B of Ortho Clinical Diagnostics Holdings stock for Q3 2021, down 13% quarter-over-quarter.
  • 37 funds opened new Ortho Clinical Diagnostics Holdings positions in Q3 2021 and 3 closed out, a net change of +34 holders.
  • The largest Ortho Clinical Diagnostics Holdings buyer in Q3 2021 was T. Rowe Price Associates, an estimated $81.9M added.
  • The largest Ortho Clinical Diagnostics Holdings seller in Q3 2021 was Carlyle Group, an estimated $509M sold.

Based on aggregated 13F filings for Q3 2021.